First performance study of ETEST® TBP (Tebipenem) for Minimum Inhibitory Concentration (MIC) determination for Enterobacterales Posted on April 21, 2022 at 8:05 am.Written by SPERO THERAPEUTICS View Presentation Post navigation Pharmacokinetics-Pharmacodynamics Evaluation of Tebipenem Pivoxil Hydrobromide Using the 10-Day Hollow-Fiber In Vitro Infection Model